The medical tourism market would be worth more than US$ 5.2 Billion in 2022. Some of the market’s main drivers are cost savings and extra advantages to visitors such as improved healthcare, new technology, breakthrough medications, sophisticated gadgets, greater hospitality, and personalised care. The size of the medical tourism industry is expected to expand at a CAGR of 30.5% between 2022 and 2032. FMI predicts that the market will be worth US$ 75 Billion by 2032. The global medical tourism industry’s growth is likely to be attributed to:

Availability of cheaper treatment options abroad without compromising on the overall standard and quality of healthcare services is the chief driver of medical tourism in the East. The field contributes significantly to the generation of revenue across developing economies, which has been motivating government aids.

Besides this various government and non-government machineries are contributing towards campaigns to encourage medical tourism. Their efforts are indicative of opportunities existing in the field. For instance, the Tourism Authority of Thailand has launched a very effective e-campaign a couple of years back to assert the country’s position in the global medical tourism landscape. Besides this, various campaigns are launched in India to promote yoga and spiritual centers within the country.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-249

key takeaways :

The U.S. is expected to lead in terms of healthcare travel spending, however, in the coming years China’s spending is forecast to surge considerably

Among services offered under medical tourism, therapeutic services are highly sought-after. Wellness services too are gaining traction as an increasing number of medical tourists are seeking meditation and wellness retreats

Phone and online booking will remain more preferred modes of booking for medical tourism

Medical tourism is often sought for cancer and cardiovascular treatment. Besides this, cosmetics and bariatric procedures are very popular among medical tourists

Medical Tourism Shows Resilience amid COVID-19

While the unprecedented COVID-19 outbreak might have caused significant disruptions, recovery is on card, thanks to prompt response by governments around the world. Thailand’s response to the ongoing pandemic, for instance, has won praise from the United Nations, the World Health Organization, and other experts around the world. Thailand has been ranked among the top five countries among 184 in terms of the effectiveness of their battle against the virus.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-249

According to the Thailand Board of Investment, more than 50 applications for investments, worth over US$ 400 million were submitted during the first half of 2020 to introduce a range of novel measures, accelerating investment in the medical sector. Proactive steps taken by government and non-government organizations will enable the medical tourism market sail despite losses incurred during COVID-19.

Who is winning?

Medical tourism market is expanding at a fast rate. Tier 1 companies such as AsklepiosKlinikenGmbH, Bangkok DusitMedical Services, Fortis Healthcare Limited, Apollo Healthcare, BumrugrandInternational Hospitals, ChristusMughuerza, and others contribute nearly 6% to 17% of revenue generated by the market.

Tier 2 companies operating in the market include Asian Heart Institute, Prince Court Medical Center, ShouldiceHospital, Gleneagles Hospital, ClemenceuMedical Centre, AnadoluMedical Centre, and others. These companies account for the lion’s share of the global market.

Key Segments

Americas

Global Healthcare Connections, Inc.

Christus Muguerza S.A.P.I De CV

Shouldice Hospital

Europe

Asklepios Kliniken GmbH

Asia-Pacific

Fortis Healthcare Ltd

Apollo Hospitals

Gleneagles Hospital

Bumrungrad international Hospital

Bangkok Dusit Medical Services

Asian Heart Institute

Prince Court Medical Center

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-249